Sentence examples for molecular and pathologic from inspiring English sources

10– 12 The aim of the present study was to assess the role of these new molecular and pathologic prognostic factors and correlate them with other clinical-pathological factors and survival data in group of cutaneous melanoma SN-positive patients after CLND, treated in 1 institution.

Desplats P, Dumaop W, Smith D, Adame A, Everall I, Letendre S, et al. Molecular and pathologic insights from latent HIV-1 infection in the human brain.

Although the cerebral consequences of cardiopulmonary bypass have been measured clinically, insights into the resulting molecular and pathologic events within the brain have only begun to be investigated.

Finally, we report that these same former players had varied performance on a test of verbal learning and memory, suggesting that these molecular and pathologic changes may play a role in cognitive decline.

Simian T cell leukemia virus (STLV 1), the simian counterpart of HTLV-1, naturally infects Old World monkeys and shares virologic, immunologic, molecular, and pathologic features with HTLV-1 [7]–[9].

All patients gave their informed consent for using their tumour sample for molecular and pathologic analysis.

Styren, S. D., Civin, W. H. & Rogers, J. Molecular, cellular, and pathologic characterization of HLA-DR immunoreactivity in normal elderly and Alzheimer's disease brain.

Based on these molecular diagnoses and pathologic review, a diagnosis of active IgAN is favored; however, significant clinicopathological overlap clearly exists between these two entities.

We prospectively investigated each patient with a surveillance protocol that assembled information about life history, previous medical history, clinical history, laboratory data, and results of molecular genetic and pathologic analyses.

For this reason, and because of the ease of use and reproducibility that can be achieved, these imagable models provide ideal systems for determining anti-metastatic effects of cancer drugs and therapeutic regimens and is well suited for investigating the molecular, cellular and pathologic basis for metastasis to specific organs and tissues.

The surveillance system was initiated in April 1999, and each patient was prospectively assessed with a surveillance protocol that assembled information about life history; previous medical history, including the history of surgical treatment and blood transfusion; clinical history; laboratory data; and results of molecular genetic and pathologic examinations.